IONIS PHARMACEUTICALS INC
CIK 874015 · last filed 2020-10-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
13
Lifetime Open-Market Net
$222.50M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AKCEA THERAPEUTICS, INC. (AKCA) Delisted | 10%+ Owner | 77,094,682 | — | — | $225.00M | 6 | 2019-12-19 |
| Regulus Therapeutics Inc. (RGLS) Delisted | Director | 5,451,172 | $8.16 | $44.48M | -$2.50M | 6 | 2015-07-17 |
Recent Filings · Page 2 of 2
13 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-07-25 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −10,500 | -$70.9K | EDGAR |
| 2014-07-07 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −8,600 | -$69.4K | EDGAR |
| 2012-10-11 | Regulus Therapeutics Inc. (RGLS) Delisted | Mixed | +7,049,500 | $3.00M | EDGAR |
Showing 11–13 of 13
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.